Citations (122)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
K. Linnet, H. Kelbæk & M. Bahnsen. (1983) Diagnostic Values of Fasting and Postprandial Concentrations in Serum of 3α-Hydroxy-Bile Acids and Gamma-Glutamyl Transferase in Hepatobiliary Disease. Scandinavian Journal of Gastroenterology 18:1, pages 49-56.
Read now
Read now
K. Linnet & H. Kelbæk. (1982) The Patterns of Glycine and Taurine Conjugates of Bile Acids in Serum in Hepatobiliary Disease. Scandinavian Journal of Gastroenterology 17:7, pages 919-924.
Read now
Read now
K. Linnet, H. Kelbák & P. Frandsen. (1982) Predictive Value of the Concentration in Serum of Total 3α-Hydroxy Bile Acids in the Diagnosis of Hepatobiliary Disease. Scandinavian Journal of Gastroenterology 17:2, pages 263-268.
Read now
Read now
I. Tulikoura & K. Huikuri. (1982) Morphological Fatty Changes and Function of the Liver, Serum Free Fatty Acids, and Triglycerides During Parenteral Nutrition. Scandinavian Journal of Gastroenterology 17:2, pages 177-185.
Read now
Read now
S.
Paul Bajaj, SamuelI. Rapaport & Christina Prodanos. (1981) A Simplified Procedure for Purification of Human Prothrombin, Factor IX and Factor X. Preparative Biochemistry 11:4, pages 397-412.
Read now
Read now
Britta Hjorth & E. Kjærsgaard. (1977) Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser. Scandinavian Journal of Clinical and Laboratory Investigation 37:1, pages 15-20.
Read now
Read now
Ib Andersen & Sixtus Thorsen. (1977) The application of the Reaction Rate Analyser LKB 8600 as an automatic coagulometer. Scandinavian Journal of Clinical and Laboratory Investigation 37:1, pages 7-13.
Read now
Read now
Ann-Catrine Teger-nilsson. (1967) A Procoagulant from Human Postpartum Serum II. Isolation and properties. Scandinavian Journal of Clinical and Laboratory Investigation 20:4, pages 339-346.
Read now
Read now
K. Grette. (1959) The Release of 5-Hydroxytryptamine (Serotonin) From Blood Platelets During Coagulation. Scandinavian Journal of Clinical and Laboratory Investigation 11:1, pages 50-56.
Read now
Read now
K.-E. Sjølin. (1956) The Thrombin Generation Test in the Diagnosis of Classical Hemophilia and Christmas Disease. Scandinavian Journal of Clinical and Laboratory Investigation 8:2, pages 138-144.
Read now
Read now
R. Gordin & B Kuhlbäck. (1954) A Bed-Side “Prothrombin” Method for Use in Anticoagulant Therapy. Scandinavian Journal of Clinical and Laboratory Investigation 6:2, pages 155-159.
Read now
Read now
H. Begtrup. (1954) Citrated or Oxalated Blood in the Determination of Prothrombin by the Method of Owren. Scandinavian Journal of Clinical and Laboratory Investigation 6:2, pages 129-130.
Read now
Read now
T. Hilden And & O. Munck. (1953) Vitamin K As Antagonist to Anticoagulants. Scandinavian Journal of Clinical and Laboratory Investigation 5:4, pages 361-365.
Read now
Read now
S. Mullertz. (1953) Dilution Curves and Accuracy in Prothrombin Estimations During Hepatitis and Dicumarol Therapy. Scandinavian Journal of Clinical and Laboratory Investigation 5:2, pages 179-187.
Read now
Read now
P. A. Owren & K. Aas. (1951) The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and Proconvertin. Scandinavian Journal of Clinical and Laboratory Investigation 3:3, pages 201-208.
Read now
Read now
P. Astrup & A. Grüner. (1951) Urinary Excretion of Hexosamines and Glucuronic Acid During Treatment with Acth. Scandinavian Journal of Clinical and Laboratory Investigation 3:3, pages 197-200.
Read now
Read now
J. Bjerkelund. (1951) A comparison between the effect of intravenously and orally administrated dicumarol on the plasma prothrombin levels in man. Scandinavian Journal of Clinical and Laboratory Investigation 3:2, pages 115-120.
Read now
Read now
J. Bjerkelund. (1950) The Effect of Phenylindanedione on Plasma Prothrombin and Factor V Levels and a Comparison with the Effect of Dicumarol. Scandinavian Journal of Clinical and Laboratory Investigation 2:2, pages 83-91.
Read now
Read now
P. A. Owren. (1949) The Diagnostic and Prognostic Significance of Plasma Prothrombin and Factor V Levels in Parenchymatous Hepatitis and Obstructive Jaundice. Scandinavian Journal of Clinical and Laboratory Investigation 1:2, pages 131-140.
Read now
Read now
Articles from other publishers (103)
G D Forwell & G I C Ingram. (1956) The Anticoagulant Activity of Dextran Sulphate. Journal of Pharmacy and Pharmacology 8:1, pages 530-543.
Crossref
Crossref
T. KNUDSEN, A.T. KRISTENSEN, B.B. SØRENSEN, O.H. OLSEN, H.R. STENNICKE & L.C. PETERSEN. (2010) Characterization of canine coagulation factor VII and its complex formation with tissue factor: canine–human cross‐species compatibility. Journal of Thrombosis and Haemostasis 8:8, pages 1763-1772.
Crossref
Crossref
N G RothnieA G NormanMuriel SteeleJ B Kinmonth. (1960) Changes in blood-coagulation due to perfusion for cardiac surgery. British Journal of Surgery 48:209, pages 272-281.
Crossref
Crossref
Jesus Weir-M, Zulay Acurero, Rodolfo Salas-A & M Arteaga-Vizcaino. (2004) Blood coagulation factors in the black headed vulture (Coragyps atratus), a potential animal model for the study of haemostasis. Thrombosis Research 113:3-4, pages 269-273.
Crossref
Crossref
William Y. SunMelissa C. BurkartJoseph R. HolahanSandra J. F. Degen. (2000) Prothrombin San Antonio: a single amino acid substitution at a Factor Xa activation site (Arg320 to His) results in dysprothrombinemia. Blood 95:2, pages 711-714.
Crossref
Crossref
P.J. Smak Gregoor, M.S. Harvey, E. Briët & A. Brand. (2003) Coagulation parameters of CPD fresh‐frozen plasma and CPD cryoprecipitate‐poor plasma after storage at 4°C for 28 days. Transfusion 33:9, pages 735-738.
Crossref
Crossref
E. Hirvonen, U.-H. Stenman, M. Mälkönen, V. Rasi, E. Vartiainen & P. Ylöstalo. (1988) New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women. Maturitas 10:3, pages 201-213.
Crossref
Crossref
S. Boccia, N. Stabellini, F. Macario & F. Ghinelli. (1987) Correspondence. Hepatology 7:2, pages 414-414.
Crossref
Crossref
A. Ruiz-Siez, J. Luengo, A. Rodriguez, A. Ojeda, O. Gômez & Z. Acurero. (1986) Prothrombin Perija: A new congenital dysprothrombinemia in an Indian family. Thrombosis Research 44:5, pages 587-598.
Crossref
Crossref
Marie-Genevi?ve Huisse, Marie Dreyfus & Marie-Claude Guillin. (1986) Prothrombin clamart : prothrombin variant with defective arg 320-IIe cleavage by factor xa. Thrombosis Research 44:1, pages 11-21.
Crossref
Crossref
S P Bajaj, S I Rapaport & S L Maki. (1985) A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.. Journal of Biological Chemistry 260:21, pages 11574-11580.
Crossref
Crossref
A. Bezeaud, L. Drouet, C. Soria & M-C. Guillin. (1984) Prothrombin Salakta : An abnormal prothrombin characterized by a defect in the active site of thrombin. Thrombosis Research 34:6, pages 507-518.
Crossref
Crossref
L.V.M. Rao & S.Paul Bajaj. (1984) Purification of human factor VII utilizing O-(diethylaminoethyl)-Sephadex and sulfopropyl-Sephadex chromatography. Analytical Biochemistry 136:2, pages 357-361.
Crossref
Crossref
S. Paul Bajaj, Samuel I. Rapaport & William A. Russell. (2002) Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX. Biochemistry 22:17, pages 4047-4053.
Crossref
Crossref
K. Linnet & J. Rye Andersen. (1983) Differential diagnostic value in hepatobiliary disease of serum conjugated bile acid concentrations and some routine liver tests assessed by discriminant analysis. Clinica Chimica Acta 127:2, pages 217-228.
Crossref
Crossref
S. Dorothy Hudig & Paul Bajaj. (1982) Tissue factor-like activity of the human monocytic tumor cell line U937. Thrombosis Research 27:3, pages 321-332.
Crossref
Crossref
P.A. Bolhuis, R.M.R. Sylva-Steenland, J.A. Tutuarima, E.A.H. Hische & H.J. van der Helm. (1982) Comparison of the spectrophotometric determination and the two-stage coagulation assay of tissue factor activity. Thrombosis Research 27:4, pages 429-434.
Crossref
Crossref
S P Bajaj, P A Price & W A Russell. (1982) Decarboxylation of gamma-carboxyglutamic acid residues in human prothrombin. Stoichiometry of calcium binding to gamma-carboxyglutamic acid in prothrombin.. Journal of Biological Chemistry 257:7, pages 3726-3731.
Crossref
Crossref
Monica Einarsson, Lennart Kaplan, Erik Nordenfelt & Eva Miller. (1981) Removal of hepatitis B virus from a concentrate of coagulation factors II, VII, IX and X by hydrophobic interaction chromatography. Journal of Virological Methods 3:4, pages 213-228.
Crossref
Crossref
Osamu Takahashi & Kogo Hiraga. (2009) Haemorrhagic Toxicosis in Rats Given Butylated Hydroxytoluene. Acta Pharmacologica et Toxicologica 49:1, pages 14-20.
Crossref
Crossref
George J. BrozeJr.Jr. & Philip W. Majerus. 1981. Proteolytic Enzymes, Part C. Proteolytic Enzymes, Part C
228
237
.
S.P. Bajaj, S.I. Rapaport & S.F. Brown. (1981) Isolation and characterization of human factor VII. Activation of factor VII by factor Xa.. Journal of Biological Chemistry 256:1, pages 253-259.
Crossref
Crossref
Hina Nishibe. (1980) The assay of factor V in plasma using a synthetic chromogenic substrate. Clinica Chimica Acta 106:3, pages 301-307.
Crossref
Crossref
M.J.N.C. Keirse, J.Bennebroek Gravenhorst, M.J. Boekhout-Mussert, J. Dubbeldam & J.J. Veltkamp. (1980) Coagulation changes during management of fetal death with 15(S)-15-methylprostaglandin F2α. European Journal of Obstetrics & Gynecology and Reproductive Biology 11:1, pages 43-48.
Crossref
Crossref
Jack Ph. Terwiel, Jan J. Veltkamp, Rogier M. Bertina & Hein P. Muller. (2008) Coagulation Factors in the Human Fetus of about 20 Weeks of Gestational Age. British Journal of Haematology 45:4, pages 641-650.
Crossref
Crossref
Bjarne ØSterud & Samuel I. Rapaport. (2009)
Activation of
125
I‐Factor IX and
125
I‐Factor X: Effect of Tissue Factor and Factor VII, Factor X
a
and Thrombin
. Scandinavian Journal of Haematology 24:3, pages 213-226.
Crossref
Crossref
R.M. Bertina, Willy Van Der Marel-Van Nieuwkoop, J. Dubbeldam, Ria J. Boekhout-Mussert & J.J. Veltkamp. (1980) New method for the rapid detection of vitamin K deficiency. Clinica Chimica Acta 105:1, pages 93-98.
Crossref
Crossref
A.R. Giles, M. Johnston, H. Hoogendoorn, M. Blajchman & J. Hirsh. (1980) The thrombogenicity of prothrombin complex concentrates: I. The relationship between characteristics and thrombogenicity in rabbits. Thrombosis Research 17:3-4, pages 353-366.
Crossref
Crossref
E. Holmer, G. Söderström & L.-O. Andersson. (1980) Properties of antithrombin III depleted plasma I. Effect of heparin. Thrombosis Research 17:1-2, pages 113-124.
Crossref
Crossref
O. Takahashi, S. Hayashida & K. Hiraga. (1980) Species differences in the haemorrhagic response to butylated hydroxytoluene. Food and Cosmetics Toxicology 18:3, pages 229-235.
Crossref
Crossref
Osamu Takahashi & Kogo Hiraga. (1979) Preventive Effects of Phylloquinone on Hemorrhagic Death Induced by Butylated Hydroxytoluene in Male Rats. The Journal of Nutrition 109:3, pages 453-457.
Crossref
Crossref
Inga Marie Nilsson, Marianne Mikaelsson, Hans Vilhardt & Helen Walter. (1979) DDAVP factor VIII concentrate and its properties in vivo and in vitro. Thrombosis Research 15:1-2, pages 263-271.
Crossref
Crossref
Bjarne ?sterud, Carol K. Kasper & Christina Prodanos. (1979) Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules. Thrombosis Research 15:1-2, pages 235-243.
Crossref
Crossref
R.M. Bertina, M. Orlando & G.H.J. Tiedemann-Alderkamp. (1978) Preparation of a human factor VII deficient plasma. Thrombosis Research 13:3, pages 537-541.
Crossref
Crossref
Frantisek Kornalik, Eva T?borsk?Dietrich Mebs. (1978) Pharmacological and biochemical properties of a venom gland extract from the snake Thelotornis kirtlandi. Toxicon 16:6, pages 535-542.
Crossref
Crossref
N. Refsum, H. Arnesen, C. C. Gilhuus‐Moe & H. C. Godal. (2009) The Relationship between Normotest and Thrombotest in Patients on Oral Anticoagulant Therapy. Scandinavian Journal of Haematology 18:4, pages 333-336.
Crossref
Crossref
Sandra Schiffman & Francis S. MarklandJr.Jr.. (1975) Effect of intermediates of extrinsic clotting on purified factor XI: Factor VII and/or thromboplastin. Thrombosis Research 6:3, pages 273-279.
Crossref
Crossref
Mark E. Legaz, Gottfried Schmer, Richard B. Counts & Earl W. Davie. (1973) Isolation and Characterization of Human Factor VIII (Antihemophilic Factor). Journal of Biological Chemistry 248:11, pages 3946-3955.
Crossref
Crossref
H. J. Breukink, H. Ch. Hart, C. Arkel, N. A. Velden & C. C. Watering. (2010) Congenital Afibrinogenemia in Goats. Zentralblatt für Veterinärmedizin Reihe A 19:8, pages 661-676.
Crossref
Crossref
Ingrid Nor?n. (1972) Clinical application of a new assay of factor VIII and factor VIII inhibitors. Thrombosis Research 1:1, pages 19-32.
Crossref
Crossref
Bjarne ØSterud, Samuel I. Rapaport, Sandra Schiffman & May M. Y. Chong. (2008) Formation of Intrinsic Factor‐X‐Activator Activity, with Special Reference to the Role of Thrombin. British Journal of Haematology 21:6, pages 643-660.
Crossref
Crossref
Sam Nordström. (2008) Inhibition of Thromboplastin‐Induced Intravascular Coagulation by Heparin and Trasylol. Acta Physiologica Scandinavica 79:3, pages 390-404.
Crossref
Crossref
Bjarne Oesterud & Samuel I. Rapaport. (2002) Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX. Biochemistry 9:8, pages 1854-1861.
Crossref
Crossref
Lewis H. Dennis, Boris E. Reisberg, James Crosbie, Dan Crozier & Marcel E. Conrad. (2008) The Original Haernorrhagic Fever: Yellow Fever. British Journal of Haematology 17:5, pages 455-462.
Crossref
Crossref
. (1969) Anticoagulant Therapy in Myocardial Infarction. New England Journal of Medicine 281:13, pages 737-739.
Crossref
Crossref
M. Bernadette Garvey, Lewis H. Dennis, Paul K. Hildebrandt & Marcel E. Conrad. (2008) Hypobaric Erythraemia: Pathology and Coagulation Studies*. British Journal of Haematology 17:3, pages 275-281.
Crossref
Crossref
Sam Nordström & Eric Zetterqvist. (1969) Effects of Epsilon Aminocaproic Acid (EACA) and Trasylol on Thromboplastin-Induced Intravascular Coagulation, Studied in Dogs with Iodine-Labelled Fibrinogen. Acta Physiologica Scandinavica 76:1-2, pages 93-105.
Crossref
Crossref
Sandra Schiffman, Ida Theodor & Samuel I. Rapaport. (2002) Separation from Russell's viper venom of one fraction reacting with factor X and another reacting with factor V. Biochemistry 8:4, pages 1397-1405.
Crossref
Crossref
C.L. Arocha-Pi?ango & M. Layrisse. (1969) FIBRINOLYSIS PRODUCED BY CONTACT WITH A CATERPILLAR. The Lancet 293:7599, pages 810-812.
Crossref
Crossref
P. A. Owren. 1969. Human Blood Coagulation. Human Blood Coagulation
300
308
.
LewisH. Dennis & MarcelE. Conrad. (1968) ANTICOAGULANT AND ANTIMALARIAL ACTION OF HEPARIN IN SIMIAN MALARIA. The Lancet 291:7546, pages 769-771.
Crossref
Crossref
SAMUEL I. RAPAPORT, PETER F. HJORT, MARY JANE PATCH & MICHAEL JEREMIC. (2009) Consumption of Serum Factors and Prothrombin During Intravascular Clotting in Rabbits. Scandinavian Journal of Haematology 3:1, pages 59-75.
Crossref
Crossref
Margaret Howell. (1965) Comparison of fibrinolysis and coagulation in Nigerian and European men. Journal of Atherosclerosis Research 5:1, pages 80-89.
Crossref
Crossref
LEIF JØRGENSEN. (1964) EXPERIMENTAL PLATELET AND COAGULATION THROMBI. Acta Pathologica Microbiologica Scandinavica 62:2, pages 189-223.
Crossref
Crossref
NIELS TYGSTRUP. (2009) The Galactose Elimination Capacity in Relation to Clinical and Laboratory Findings in Patients with Cirrhosis. Acta Medica Scandinavica 175:3, pages 291-300.
Crossref
Crossref
Arnold G. Ware, Rex E. Sterling & Robert Stragnell. (2016) Anticoagulant Therapy. Angiology 15:1, pages 11-16.
Crossref
Crossref
Samuel I. Rapaport & Sara B. Ames. (1962) Relation between Levels of Plasma Thromboplastin Component (PTC) and Prothrombin Times by the P&P and Quick Methods in Patients Receiving Warfarin. New England Journal of Medicine 267:3, pages 125-130.
Crossref
Crossref
J.C. Erwin. (1962) Interpretation of Laboratory Tests in Diagnosis of Hemorrhagic Disorders. Medical Clinics of North America 46:1, pages 63-78.
Crossref
Crossref
ARMAND J. QUICK. (1961) Clinical Interpretation of the One-Stage Prothrombin Time. Circulation 24:6, pages 1422-1428.
Crossref
Crossref
Theodore Rodman, Bernard H. Pastor & Kennedy C. Fawcett. (1961) A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. The American Journal of Medicine 31:4, pages 547-554.
Crossref
Crossref
John C. Owens, Charles A. ArmbrustJr.Jr., William C. Sutton, William R. Livesay & Ephraim L. Wagner. (1961) Determination of prothrombin concentration as an index of anticoagulant control. The American Journal of Cardiology 8:4, pages 471-480.
Crossref
Crossref
K. M. Dormandy & R. M. Hardisty. (1961) Coagulation tests on capillary blood: A screening procedure for use in small children. Journal of Clinical Pathology 14:5, pages 543-547.
Crossref
Crossref
G. I. C. Ingram. (1961) A suggested schedule for the rapid investigation of acute haemostatic failure. Journal of Clinical Pathology 14:4, pages 356-360.
Crossref
Crossref
E. A. MURPHY & J. F. MUSTARD. (1960) Dicumarol Therapy. Circulation Research 8:6, pages 1187-1199.
Crossref
Crossref
G.I.C. Ingram, P. R. Norris & Elizabeth I. Tanner. (2005) ACUTE COAGULATION DISORDERS AT PARTURITION. BJOG: An International Journal of Obstetrics & Gynaecology 67:3, pages 367-383.
Crossref
Crossref
Kenneth M. Moser. (1960) Use of anticoagulant and fibrinolytic agents. Disease-a-Month 6:3, pages 1-44.
Crossref
Crossref
Marc Verstraete, C. Vermylen & J. Vandenbroucke. (2009) Measurement of Overall Coagulability during Coumarin Treatment with Reference to the Quick Test. Acta Medica Scandinavica 167:2, pages 127-138.
Crossref
Crossref
Arthur J. Seaman & Ralph C. Benson. (1960) Coagulation studies of patients with abnormal uterine bleeding. American Journal of Obstetrics and Gynecology 79:1, pages 5-10.
Crossref
Crossref
N. D. Hicks & J. A. Bonnin. (2008) The Behaviour of Coagulation Factors during Anticoagulant Therapy with Special Reference to the One‐Stage Test as an Index of Therapy. British Journal of Haematology 5:2, pages 194-202.
Crossref
Crossref
K. B. BJÖRNESJÖ & FRITZ KARLSTRÖM. (2008) Prothrombin Determination in Infants: A Comparison of the Methods of Quick‐Lehmann and Owren. Acta Paediatrica 47:6, pages 626-634.
Crossref
Crossref
Ian Cope & E. Simons. (2005) THE FIBRINOLYTIC ACTIVITY OF UMBILICAL CORD BLOOD. BJOG: An International Journal of Obstetrics & Gynaecology 65:3, pages 414-418.
Crossref
Crossref
M. A. PEYMAN. (2009) THE SIGNIFICANCE OF HAEMORRHAGE DURING THE TREATMENT OF PATIENTS WITH THE COUMARIN ANTICOAGULANTS. Acta Medica Scandinavica 162:S339, pages 1-62.
Crossref
Crossref
. (1957) LIFE WITH A DUODENAL ULCER. The Lancet 270:7000, pages 849-850.
Crossref
Crossref
F. Gray. (1957) HEALTH CENTRES: NEW PATTERNS. The Lancet 270:7000, pages 849.
Crossref
Crossref
Louis Steingold, D.W.G. Smith, A.A. Roberts & M. Toohey. (1957) ESTIMATION OF PLASMA-PROTHROMBIN. The Lancet 270:7000, pages 849.
Crossref
Crossref
V. P. Baluda. (1957) Presence of components of thromboplastin in erythrocytes. Bulletin of Experimental Biology and Medicine 44:3, pages 1029-1031.
Crossref
Crossref
N. D. Hicks & W. R. Pitney. (2008) A Rapid Screening Test for Disorders of Thromboplastin Generation. British Journal of Haematology 3:2, pages 227-237.
Crossref
Crossref
W. R. PITNEY. (1957) MILD HAEMOPHILIA-A CLINICAL AND LABORATORY STUDY. Australasian Annals of Medicine 6:1, pages 44-52.
Crossref
Crossref
IRVING SCHULMAN & CARL H. SMITH. (1957) Coagulation Disorders in Infancy and Childhood. Advances in Pediatrics 9:1, pages 231-276.
Crossref
Crossref
TORBEN IVERSEN & POUL BASTRUP‐MADSEN. (2008) Congenital Familial Deficiency of Factor V (Parahaemophilia) Combined with Deficiency of Antihaemophilic Globulin. British Journal of Haematology 2:3, pages 265-275.
Crossref
Crossref
W. R. Pitney. (2008) The Assay of Antihaemophilic Globulin (AHG) in Plasma. British Journal of Haematology 2:3, pages 250-264.
Crossref
Crossref
T. BENNIKE & L. C. GRANDJEAN. (2009) Hemorrhagic Diathesis in Poliomyelitis. Acta Medica Scandinavica 155:3, pages 225-236.
Crossref
Crossref
TORBEN IVERSEN. (2009) Anticoagulant Therapy with Tromexan and Marcoumar and Determination of the Prothrombin‐Proconvertin Activity by a Micro‐Method. Acta Medica Scandinavica 155:3, pages 161-170.
Crossref
Crossref
G. I. C. Ingram. (1955) Variations in the Reaction Between Thrombin and Fibrinogen and their Effect on the Prothrombin Time. Journal of Clinical Pathology 8:4, pages 318-323.
Crossref
Crossref
R. M. Hardisty. (2008) The Reaction of Blood Coagulation Factors with Brain Extract. British Journal of Haematology 1:3, pages 323-332.
Crossref
Crossref
C. Merskey & Elizabeth Scholtz. (2008) Technical Objectives in the Control of Anticoagulant Therapy. British Journal of Haematology 1:3, pages 308-322.
Crossref
Crossref
JAN W. MURI. (2009) Long‐Term Treatment with Dicumarol in Myocardial Infarction. Acta Medica Scandinavica 153:5, pages 363-366.
Crossref
Crossref
W. Walker & R. B. Hunter. (1954) The Mode of Action of Phenylindanedione. Journal of Clinical Pathology 7:3, pages 249-251.
Crossref
Crossref
R. M. Hardisty. (1954) "Acquired Haemophilia-like Disease": Report of a Case with Studies on the Mode of Action of the Circulating Anticoagulant. Journal of Clinical Pathology 7:1, pages 26-28.
Crossref
Crossref
HOLGER DYGGVE & ERLING LUND. (2009)
Micromethod for the Quantitative Determination of Plasma Prothrombin and Proconvertin
1
. Acta Medica Scandinavica 150:3, pages 207-214.
Crossref
Crossref
HOLGER BEGTRUP. (2009)
Comparison of Two Methods for Determining Prothrombin during Dicumarol Therapy
1
. Acta Medica Scandinavica 150:1, pages 11-16.
Crossref
Crossref
FINN FISCHER & ERLING LUND. (2009)
The Blood Coagulation Mechanism with Especial Reference to the Prothrombin‐Proconvertin Contents of Plasma during Long‐Term ACTH or Cortisone Therapy
1
. Acta Medica Scandinavica 149:3, pages 179-185.
Crossref
Crossref
RUBEN GORDIN. (2009) Prothrombin in Cryptogenetic Pernicious Anemia and Pernicious Tapeworm Anemia and its Response to Treatment. Acta Medica Scandinavica 149:1, pages 1-18.
Crossref
Crossref
E. K. Blackburn. (1953) Modern Treatment of Pernicious Anaemia. International Journal of Clinical Practice 7:7, pages 511-516.
Crossref
Crossref
W.G. Rice & Sister Mary Eloise. (1953) Deficient prothrombin and fibrinogen in fatalerythroblastosis fetalis. The Journal of Pediatrics 42:2, pages 231-234.
Crossref
Crossref
P.A. Owren. (1953) Prothrombin and accessory factors. The American Journal of Medicine 14:2, pages 201-215.
Crossref
Crossref
ERLING LUND. (2009)
Long Term Dicumarol Therapy in Thromboembolic Conditions, Especially Coronary Thrombosis.
1
. Acta Medica Scandinavica 146:4, pages 252-258.
Crossref
Crossref
CHR. J. BJERKELUND & ESTHER GLEDITSCH. (2009) Hypoprothrombinemia — Occurrence and Prognostic Significance in Congestive Heart Failure.. Acta Medica Scandinavica 145:3, pages 181-188.
Crossref
Crossref
Mario Stefanini. (1953) Mechanism of blood coagulation in normal and pathologic conditions. The American Journal of Medicine 14:1, pages 64-86.
Crossref
Crossref
Anton Fonio. 1953. Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde
1
51
.
Robert Stragnell. (1952) Intravenous emulsified vitamin K1 in the treatment of coumarin-induced hypoprothrombinemia. American Heart Journal 44:1, pages 124-130.
Crossref
Crossref
N. Vinther-Paulsen. (2016) Thrombophlebitis Migrans. Angiology 3:2, pages 194-201.
Crossref
Crossref
J. Erik Jorpes. 1951. Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde
6
48
.